theralizumab (TAB08) / TheraMab  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
theralizumab (TAB08) / TheraMab
TAB08, NCT03006029: Dose Escalation Study of in Patients With Advanced Solid Neoplasms

Completed
1b
12
RoW
TAB08, Theralizumab
Theramab LLC
Solid Tumors
05/19
08/19
NCT01885624: Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers

Completed
1
31
RoW
TAB08
Theramab LLC
Adult Healthy Volunteers
05/13
06/13

Download Options